Tumor necrosis factor-α: is there a continuum of liability between stress, anxiety states and anorexia nervosa?
Since the time of Freud, psychiatry has embraced the proposition that physiological and/or psychological stress precipitates various psychiatric disorders. To this effect, we propose that a continuum of liability obtains between stress, anxiety states and anorexia nervosa – a continuum which is grou...
Gespeichert in:
Veröffentlicht in: | Medical hypotheses 1999-02, Vol.52 (2), p.155-162 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Since the time of Freud, psychiatry has embraced the proposition that physiological and/or psychological stress precipitates various psychiatric disorders. To this effect, we propose that a continuum of liability obtains between stress, anxiety states and anorexia nervosa – a continuum which is grounded on a cytokine profile common to each of these conditions. For example, the biological response to stress, anxiety states and anorexia nervosa includes the elevation of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), and downregulation of interferon-γ (IFN-γ). Sustained elevation of IL-1β and TNF-α dysregulates both somatostatin and insulin secretion, the latter of which influences regional cerebral blood flow (rCBF) and brain energy metabolism. In addition, IL-1β and TNF-α influence the expression of certain crucial neuropeptides, which are known to be associated with anxiety states and anorexia nervosa. These neuropeptides include: β-endorphin, cholecystokinin (CCK), neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP). β-endorphin effects glucose metabolism in the limbic system, CCK increases the release of β-endorphin from the anterior pituitary, NPY is a powerful anxiolytic that regulates β-endorphin and insulin, while VIP indirectly regulates the expression of TNF-α through the inhibition of interleukin-4 (IL-4). |
---|---|
ISSN: | 0306-9877 1532-2777 |
DOI: | 10.1054/mehy.1997.0641 |